Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Lécuyer D, Nardacci R, Tannous D, Gutierrez-Mateyron E, Deva Nathan A, Subra F, Di Primio C, Quaranta P, Petit V, Richetta C, Mostefa-Kara A, Del Nonno F, Falasca L, Marlin R, Maisonnasse P, Delahousse J, Pascaud J, Deprez E, Naigeon M, Chaput N, Paci A, Saada V, Ghez D, Mariette X, Costa M, Pistello M, Allouch A, Delelis O, Piacentini M, Le Grand R, Perfettini JL. Lécuyer D, et al. Among authors: maisonnasse p. Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.
A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model.
Fovet CM, Pimienta C, Galhaut M, Relouzat F, Nunez N, Cavarelli M, Sconosciuti Q, Dhooge N, Marzinotto I, Lampasona V, Tolazzi M, Scarlatti G, Ho Tsong Fang R, Naninck T, Dereuddre-Bosquet N, Van Wassenhove J, Gallouët AS, Maisonnasse P, Le Grand R, Menu E, Seddiki N. Fovet CM, et al. Among authors: maisonnasse p. Front Immunol. 2022 May 4;13:855230. doi: 10.3389/fimmu.2022.855230. eCollection 2022. Front Immunol. 2022. PMID: 35603150 Free PMC article.
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Maisonnasse P, Guedj J, Contreras V, Behillil S, Solas C, Marlin R, Naninck T, Pizzorno A, Lemaitre J, Gonçalves A, Kahlaoui N, Terrier O, Fang RHT, Enouf V, Dereuddre-Bosquet N, Brisebarre A, Touret F, Chapon C, Hoen B, Lina B, Calatrava MR, van der Werf S, de Lamballerie X, Le Grand R. Maisonnasse P, et al. Nature. 2020 Sep;585(7826):584-587. doi: 10.1038/s41586-020-2558-4. Epub 2020 Jul 22. Nature. 2020. PMID: 32698191
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.
Maisonnasse P, Poynard T, Sakka M, Akhavan S, Marlin R, Peta V, Deckmyn O, Ghedira NB, Ngo Y, Rudler M, van der Werf S, Marot S, Thabut D, Sokol H, Housset C, Combes A, Le Grand R, Cacoub P. Maisonnasse P, et al. Gastro Hep Adv. 2022;1(3):393-402. doi: 10.1016/j.gastha.2021.12.009. Epub 2022 Feb 7. Gastro Hep Adv. 2022. PMID: 35174366 Free PMC article.
Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque.
Olivo A, Marlin R, Lazure T, Maisonnasse P, Bossevot L, Mouanga C, Lemaitre J, Pourcher G, Benoist S, Le Grand R, Lambotte O, Dereuddre-Bosquet N, Bourgeois C. Olivo A, et al. Among authors: maisonnasse p. Commun Biol. 2022 Jun 3;5(1):542. doi: 10.1038/s42003-022-03503-9. Commun Biol. 2022. PMID: 35661814 Free PMC article.
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J. Marc A, et al. Among authors: maisonnasse p. PLoS Comput Biol. 2023 Aug 9;19(8):e1010721. doi: 10.1371/journal.pcbi.1010721. eCollection 2023 Aug. PLoS Comput Biol. 2023. PMID: 37556476 Free PMC article.
[COVID-19: Warp Speed vaccines].
Feraoun Y, Maisonnasse P, Le Grand R, Beignon AS. Feraoun Y, et al. Among authors: maisonnasse p. Med Sci (Paris). 2021 Aug-Sep;37(8-9):759-772. doi: 10.1051/medsci/2021094. Epub 2021 Jun 3. Med Sci (Paris). 2021. PMID: 34080537 Free article. Review. French.
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Sulbaran G, Maisonnasse P, Amen A, Effantin G, Guilligay D, Dereuddre-Bosquet N, Burger JA, Poniman M, Grobben M, Buisson M, Dergan Dylon S, Naninck T, Lemaître J, Gros W, Gallouët AS, Marlin R, Bouillier C, Contreras V, Relouzat F, Fenel D, Thepaut M, Bally I, Thielens N, Fieschi F, Schoehn G, van der Werf S, van Gils MJ, Sanders RW, Poignard P, Le Grand R, Weissenhorn W. Sulbaran G, et al. Among authors: maisonnasse p. Cell Rep Med. 2022 Jan 24;3(2):100528. doi: 10.1016/j.xcrm.2022.100528. eCollection 2022 Feb 15. Cell Rep Med. 2022. PMID: 35233549 Free PMC article.
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection.
Alexandre M, Marlin R, Prague M, Coleon S, Kahlaoui N, Cardinaud S, Naninck T, Delache B, Surenaud M, Galhaut M, Dereuddre-Bosquet N, Cavarelli M, Maisonnasse P, Centlivre M, Lacabaratz C, Wiedemann A, Zurawski S, Zurawski G, Schwartz O, Sanders RW, Le Grand R, Levy Y, Thiébaut R. Alexandre M, et al. Among authors: maisonnasse p. Elife. 2022 Jul 8;11:e75427. doi: 10.7554/eLife.75427. Elife. 2022. PMID: 35801637 Free PMC article.
39 results